Last checked at 24 Jul 2020 17:23
IN BRIEF: ValiRx Raises GBP300,700 From Broker Option
IN BRIEF: ValiRx Raises GBP300,700 From Broker Option
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
ValiRx Share News (VAL)
VAL Share
Price
VAL Share
News
VAL Share
Chat19
VAL Share
Trades19
VAL
Live RNS
VAL Share
Charts
VAL Level 2
Console
VAL Live
Share Price
VAL Broker
Ratings
VAL Directors
Deals
VAL Financial
Diary
VAL
Fundamentals
VAL Short
Positions
VAL
Media
ValiRx Information
Share Price Information for ValiRx (VAL)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
3.30
Bid:
3.20
Ask:
3.40
Change:
-0.15 (-4.35%)
Spread:
0.20 (6.25%)
Open:
3.45
High:
3.45
Low:
3.25
Prev. Close:
3.45
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.23 Jul 2020 18:02
UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump
UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump
Read more16 Jul 2020 15:57
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more6 Jul 2020 18:19
IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus
IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus
Read more6 Jul 2020 09:31
ValiRx looks to build on portfolio of drug candidates
(Sharecast News) - Medicines developer ValiRx said on Monday that it was looking to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health.
Read more1 Jul 2020 13:10
IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall
IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall
Read more16 Jun 2020 13:58
IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement
IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement
Read more8 Jun 2020 15:39
ValiRx Delays Annual Results Amid Covid-19 Pandemic
ValiRx Delays Annual Results Amid Covid-19 Pandemic
Read more2 Jun 2020 12:57
UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million
UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million
Read more2 Jun 2020 12:03
ValiRx enters collaboration agreement for Covid-19 treatment
(Sharecast News) - Biotechnology oncology company ValiRx has entered into a collaboration agreement with Oncolytika and Black Cat Bio to explore the use of VAL201 in a combination treatment for patients suffering a hyperimmune response to Covid-19.
Read more29 May 2020 15:02
UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App
UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App
Read more29 May 2020 12:59
ValiRx offloads non-core IP to DDTech
(Sharecast News) - ValiRx has entered into a deed of assignment with Drug Discovery Technologies (DDTech) for the patents, materials and know-how associated with its non-core intellectual property 'FitBio' and 'TRAC', it announced on Friday.
Read more27 May 2020 14:20
UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair
UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair
Read more7 May 2020 14:45
UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair
UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair
Read more4 May 2020 16:18
REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out
REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out
Read more